Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8458619 | Radiotherapy and Oncology | 2018 | 9 Pages |
Abstract
We tested the predictive value of a “31-gene signature” and PD-L1 expression status in a dataset of patients with lower grade glioma. Our results suggest that the patient population classified as the PD-L1-high-RR may benefit most from radiotherapy combined with anti-PD-1/PD-L1 treatment. Prospective clinical trial is necessary to validate the findings in a homogenous treated patient cohort.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Bum-Sup Jang, In Ah Kim,